The domain of adipose tissue transplantation in plastic surgery has significantly evolved. Originating from Gustav Neuber’s foundational work in 1893, the field has experienced a paradigm shift, especially with the advent of liposuction, leading to a spectrum of sophisticated fat grafting methodologies. These methods, including macrofat, millifat, and microfat grafting, differ in cannula sizes, processing techniques, and clinical applications, each tailored to optimize graft survival and functional outcomes. A pivotal development in this evolution is the concept of lipograft enrichment with stromal vascular fraction (SVF), aimed primarily at enhancing the regenerative potential of transplanted tissue. This has led to the advent of nanofat and lipoconcentrate. Lipoconcentrate produces a graft exceptionally rich in adipose-derived stem cells (ASCs) and endothelial progenitor cells. This enrichment translates into potent regenerative capacity, impacting tissue quality, skin texture, elasticity, color, and improving neovascularization and healing. Furthermore, lipoconcentrate refines the concept of nanofat by eliminating less crucial components for regeneration, such as the oily and watery fractions, which have no regenerative potential. The introduction of lipoconcentrate in plastic surgery not only represents a significant advancement in fat grafting techniques but also broadens therapeutic possibilities, offering a more precise and effective approach for both aesthetic and reconstructive challenges.